Glucose intolerance during prolonged sevoflurane anaesthesia Purpose 
Anaesthesia and surgery may alter many aspects of carbohydrate metabolism. It has been shown that hyperglycaemia originates from both depressed insulin secretion and increased stimulation of glucose production during anaesthesia, t,2 The purpose of this study was to determine the effects of prolonged sevoflurane anaesthesia and surgery on insulin sensitivity.
Methods
Informed consent was obtained from eight patients (age 45-67 yr.) who were scheduled for sevoflurane anaesthesia for radical neck resection and reconstruction. All were healthy (ASA physical status I-II) with biochemical screening within the normal range. Patients were excluded from the study if they had taken any medication known to affect glucose metabolism or insulin release.
All patients fasted overnight and received hydroxyzine (i mg-kg -1) and atropine (0.01 mg-kg -I) im one hour before anaesthesia. All studies were initiated before 0900 hr. Anaesthesia was induced with 5 mg. kg -I thiamylal sodium and maintained with sevoflurane 1.5-2.5%, vecuronium bromide and endotracheal nitrous oxide 60% in oxygen. Lactated Ringer's solution was infused at a rate of 7 ml. kg -1. hr-k No glucose was administered until the glucose tolerance test. Blood samples were obtained from an arterial catheter cannulated for blood pressure monitoring.
The effects of prolonged sevoflurane anaesthesia and surgery on insulin sensitivity were investigated by two successive intravenous glucose tolerance tests (IVGTT). Arterial blood samples to measure baseline blood glucose and plasma insulin were drawn prior to anaesthesia induction, 30 min after induction, and 30 min after initiation of surgery. Following these baseline measurements, each patient underwent an IVGTT 35 min after initiation of surgery. Glucose (25 g as 20% dextrose in water iv) was administered over two minutes. Zero-time was determined to be when the glucose bolus had been injected. Arterial blood samples then were obtained at 5, 10, 30, 60, and 120 min after glucose administration for blood glucose and plasma insulin determinations. Patients received a second IVGTT six hours after initiation of surgery under the same conditions. Blood glucose concentrations were determined by the glucose oxidaze method. Plasma immunoreactive insulin levels were determined by radioimmunoassay.
The rate of disappearance of glucose (k-value) was calculated by the Ikkos-Luft method. 3 The maximum insulin response to glucose (AIRI. ABS -t) was calculated by dividing the maximum changes of insulin levels from the prestimulus level by the maximum changes of blood glucose levels from the prestimulus level following the glucose load. The total insulin output was estimated as the integrated area (linear trapezoidal method) under the insulin curve above baseline levels from 0 to 60 min.
Statistical analysis included the Wilcoxon rank sum test for intergroup comparisons. Demographic variables and the baseline values were examined by one-way analysis of variance. Statistical significance was defined as P < 0.05. All data are presented as mean values _+ SD.
Results
The mean duration of anaesthesisa was 10.8 +_ 1.1 hr. The figure shows the changes in mean blood glucose and insulin (IRI) levels during the two successive IVGTTs. Baseline glucose values determined immediately before each glucose bolus were not different with the two IVGTTs. Maximal glucose values were obtained in both IVGTTs five minutes after iv glucose administration; however, by 120 rain, concentrations The mean baseline insulin levels also were not different with the two IVGTTs. During both IVGTTs, plasma insulin concentrations reached a peak five minutes after glucose administration in response to blood glucose changes. The AIRI.ABS -t of the second IVGTT was lower than that of the first IVGTT (0.124 +_ 0.092 vs 0.071 +__ 0.056, P < 0.05). The mean total insulin output was significantly higher in the first IVGTT (1,161 _+ 830 tJU" min. m1-1) compared with the second IVGTT output (568 _+ 389, P < 0.02).
Discussion
These results indicate diminished glucose tolerance in patients undergoing prolonged sevoflurane anaesthesia and surgery. With the anaesthetized patients serving as their own controls, a direct comparison of glucose and insulin concentrations with two IVGTT could be performed. The second IVGTT results suggest diminished glucose tolerance with prolonged sevoflurane anaesthesia. Prolonged anaesthesia and surgery caused marked depression of insulin output as well as depression of the maximum insulin response to a glucose challenge. Successive glucose administration improves carbohydrate tolerance and is known as the Stanb-Traugott effect. 5, 6 This effect has been shown to be associated with persistent elevation of serum immunoreactive insulin levels. In this study, raised insulin levels did not occur before the second glucose load. The impaired a response to a glucose bolus may have been due absence of the Staub-Traugott effect as the total a output was reduced in the second IVGTT. ~na et al. 7 studied the effects of sevoflurane Jaesia and surgery on endocrine functions in surgical patients. They concluded that sevoflurane combined with nitrous oxide anaesthesia alone for 20 min decreased plasma insulin levels. However, in our study, there were no differences in insulin concentrations between preanaesthesia induction, 30 min after induction of anaesthesia, and 30 min following the initiation of surgery. In this study, with sevoflurane anaesthesia, the k-value of the first IVGTT showed enhancement of glucose intolerance through a diminished response to insulin action similar to isoflurane anaesthesia with surgical stimulation. 4 It is important to recognize that prolonged anaesthesia and surgery lead to glucose intolerance with a low insulin output. Therefore, when prolonged anaesthesia is planned, glucose tolerance should be assessed preoperatively. The administration of carbohydrates must be approached carefully in patients with disordered glucose tolerance who undergo prolonged anaesthesia and surgery.
